BloomWell Rx vs Hers
BloomWell Rx and Hers both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
BloomWell Rx
Best for: seeing what it charges before you answer any medical questions
Visit BloomWell Rx →
Hers
Best for: coverage in all 50 states, which most sellers will not confirm
Visit Hers →If you are choosing between BloomWell Rx and Hers, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. They tie at 6.6 on our six-part score. One of the two has an FDA warning letter on record, covered below.
BloomWell Rx vs Hers price
BloomWell Rx and Hers start at the same figure, $199 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $199 a month; tirzepatide is cheaper at BloomWell Rx ($249 a month vs $299 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format, BloomWell Rx prices compounded injections, while Hers prices compounded injections and brand-name pens.
If you want the FDA-approved brand rather than a compounded version, Hers is the only one of the two with a brand-name price.
Where each one treats patients
BloomWell Rx does not publish where it ships, and Hers lists 50 states.
Pricing
BloomWell Rx
Hers
Brand Zepbound from $299/mo medication-only; requires Hers Weight Loss Membership ($149/mo)
What each price covers
Both prices cover the medication itself.
BloomWell Rx's price also covers the clinician visit and shipping, which Hers does not claim.
BloomWell Rx is silent on lab work and coaching.
Hers is silent on shipping and lab work.
BloomWell Rx
Covered by the monthly price
Medication
In the price
Clinician visits
In the price
Shipping
In the price
Lab work
Not stated
Coaching
Not stated
Hers
Covered by the monthly price
Medication
In the price
Clinician visits
Charged on top
Shipping
Not stated
Lab work
Not stated
Coaching
Charged on top
Where each one scores higher
Overall they tie at 6.6 out of 10.
BloomWell Rx is stronger on trust & safety (6.5 vs 5.5) and support (7.0 vs 3.0).
Hers is stronger on accessibility (10.0 vs 5.0).
Value, effectiveness and user experience are within half a point.
BloomWell Rx
6.6/10
Hers
6.6/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
The FDA sent Hers a warning letter dated September 9, 2025 (letter 716825), and it is still open.
BloomWell Rx has no FDA warning letter on record with us.
Features & Coverage
| Feature | BloomWell Rx | Hers |
|---|---|---|
| Starting Price | $199/mo | $199/mo |
| Features | ✓8 features | 2 features |
| States Available | Not disclosed | 50 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | ✓None | 1 letter |
About BloomWell Rx
A free visit precedes pricing that begins at $199/mo for personalized compounded semaglutide and $249/mo for tirzepatide, marketed as GLP-1+GIP. NAD+, sermorelin and glutathione are sold beside them, and the service is 100% online. BloomWell says plainly that it is neither a pharmacy nor a manufacturer: a licensed third party compounds and dispenses. A complete legal suite is up. That third party is never named, no LegitScript certification appears, and a marketing agency operates the site with the medical entity left unclear.
Read our full BloomWell Rx review →About Hers
Hers is the women-focused telehealth brand from Hims and Hers. It sells compounded semaglutide on a 6-month plan.
Read our full Hers review →Pros & Cons
BloomWell Rx
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication, clinician visits and shipping
- We found no FDA warning letters issued to BloomWell Rx
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Hers
What we like
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price includes the medication
- Serves all 50 states
Watch-outs
- Not included in the monthly price: clinician visits, coaching
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- The FDA has issued Hers a warning letter. Read what it alleges: a letter flags a problem but does not by itself rule a seller out
- Its semaglutide is compounded rather than FDA-approved, so it has not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
BloomWell Rx and Hers finish level at 6.6. Choose on the state list and on what each monthly price covers.
Choose BloomWell Rx if…
You want seeing what it charges before you answer any medical questions and an opening price near $199 a month.
Choose Hers if…
You want coverage in all 50 states, which most sellers will not confirm and an opening price near $199 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →BloomWell Rx vs Hers: FAQ
Close alternatives to BloomWell Rx and Hers
- BloomWell Rx vs Hims
- BloomWell Rx vs Curex
- BloomWell Rx vs HumeCare+
- Hers vs Hims
- Hers vs Care Bare Rx
- Hers vs Concierge MD LA
Or see the full category ranking.
Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.